Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 3 × Advanced Breast Cancer × Everolimus × Clear all

Phase

Phase 3 1 Phase 2 1

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Breast Neoplasms 18 Carcinoma, Renal Cell 8 Neuroendocrine Tumors 6 Tuberous Sclerosis 3 Neoplasm Metastasis 3 Kidney Neoplasms 3 Triple Negative Breast Neoplasms 2 Stomach Neoplasms 2 Seizures 2 Neoplasms 2 Gastro-enteropancreatic neuroendocrine tumor 2 Carcinoma 2 Carcinoid Tumor 2 Astrocytoma 2 von Hippel-Lindau Disease 1 Unilateral Breast Neoplasms 1 Tuberous Sclerosis Complex-associated Refractory Seizures 1 Tuberous Sclerosis 2 1 Thymus Neoplasms 1 Stomach Diseases 1 Skin Neoplasms 1 Renal Cell Cancer Metastatic 1 Recurrence 1 Prostatic Neoplasms 1 Primary Non-metastatic Breast Cancer 1 Polycystic Kidney, Autosomal Dominant 1 Malignant Carcinoid Syndrome 1 Lymphoma, Large B-Cell, Diffuse 1 Lymphoma, B-Cell 1 Lymphoma 1

Interventions

Fulvestrant 5 Anastrozole 5 Letrozole 3 exemestane 2 Goserelin 2 ribociclib 1 palbociclib 1 entinostat 1 elacestrant 1 apatinib 1 abemaciclib 1 Selective Estrogen Receptor Modulators 1 RAD1901 1 Paclitaxel 1 Injections 1 Gonadotropin-Releasing Hormone 1 FCN-437c 1 Everolimus 1 Aromatase Inhibitors 1 AZD9833 1 AZD5305 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT06382948 2026-04-03

ADELA

MedSIR

Phase 3 Recruiting

Advanced Breast Cancer

Data powered by HemOnc (CC BY 4.0) Colophon ⚡